Serum vascular adhesion protein-1 level is higher in smokers than non-smokers

Autor: Mao-Shin Lin, David Smith, Lee-Ming Chuang, Jani Vanio, Jung-Nan Wei, Yi-Chia Wang, Cyue-Huei Hua, Shyang-Rong Shih, Hung-Yuan Li
Rok vydání: 2013
Předmět:
Zdroj: Annals of Human Biology. 40:413-418
ISSN: 1464-5033
0301-4460
DOI: 10.3109/03014460.2013.788679
Popis: Semicarbazide-sensitive amine oxidase (SSAO)/vascular adhesion protein-1 (VAP-1) is involved in the pathogenesis of both atherosclerosis and cancer. Because chemical components and metabolites of cigarettes are deaminated by SSAO, the relationship between smoking and serum SSAO/VAP-1 was studied in humans.A total of 451 non-diabetic and normoalbuminuric Han Chinese subjects were recruited to participate in this study. Smoking history was obtained by using a questionnaire and those who smoked more than 100 cigarettes during a 6-month period were considered smokers. Serum VAP-1 concentration was measured by time-resolved immunofluorometric assay. Age, gender, waist circumference and estimated glomerular filtration rate (GFR) were adjusted in different statistical models.Smokers were mainly male (85.7% versus 26.3%) and were more obese than non-smokers (p 0.05). Subjects with higher serum VAP-1 concentrations were older (p 0.001) and tended to have larger waist circumferences and lower estimated GFR. Serum VAP-1 concentration was higher in smokers than in non-smokers (p 0.05) after adjusting for age, gender, waist circumference, estimated GFR, liver biochemistry and lipid profile.Cigarette smoking is associated with elevated serum VAP-1 concentration. Whether VAP-1 and its SSAO activity link the relationship between cigarette smoking, atherosclerosis and cancer requires further investigation.
Databáze: OpenAIRE
Nepřihlášeným uživatelům se plný text nezobrazuje